GLP-1 Market
LLY $1115.70 ▼ -0.7% NVO $43.07 ▼ -2.1% PFE $27.72 ▲ +0.3% VKTX $31.98 ▼ -0.5% KLRA $13.94 ▼ -6.5% GPCR $38.66 ▼ -2.3% RHHBY $52.82 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Dextrose infusion

Company
University at Buffalo
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 12, 2026

Find a Clinical Trial Near Me

See recruiting studies for Dextrose infusion and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06126419

    Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 70 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration
    View official trial listing →
  • Withdrawn NCT NCT00753740

    Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

    Not yet reported NewLink Genetics Corporation Est. completion 2010-05 7 sites
    Other conditions: Cancer, Ovarian Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT00995670

    Ischemia/Reperfusion Injury of Human Endothelium: Role of Glucose and Statins

    Not yet reported US Department of Veterans Affairs 59 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01151605

    The Suppression of Toll Like Receptors by Insulin

    Not yet reported University at Buffalo 42 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01187329

    The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose

    Not yet reported The Cleveland Clinic 100 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis, Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01300260

    Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2011-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01528189

    Effect of High Dose Insulin on Infectious Complications Following Major Surgery

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 480 participants Est. completion 2025-09-01 3 sites
    Other conditions: Surgical Site Infection After Major Surgery
    View official trial listing →
  • Completed NCT NCT01614769

    Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)

    Not yet reported Merck Sharp & Dohme LLC 10 participants Est. completion 2013-01-23 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01688674

    Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia

    Not yet reported Makerere University 140 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.
    View official trial listing →
  • Terminated NCT NCT01713127

    Remifentanil in Ventilated Preterm Infants

    Not yet reported, Not yet reported Seoul National University Hospital 12 participants Est. completion 2013-02 1 site
    Other conditions: Preterm Infants, Mechanical Ventilator Care
    View official trial listing →
  • Completed NCT NCT01819844

    Inpatient Closed-loop Glucose Control

    Not yet reported Massachusetts General Hospital 12 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Hyperglycemia
    View official trial listing →
  • Withdrawn NCT NCT01828125

    Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal Est. completion 2013-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT02023489

    Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

    Not yet reported Medical University of Vienna 90 participants Est. completion 2018-07 1 site
    Type 2 diabetesPrediabetes Other conditions: Familiar Hypocalcuric Hypercalcemia, Healthy Volunteers, Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02032953

    Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 24 participants Est. completion 2024-04 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02102243

    Neural Mechanism of Aldosterone-induced Insulin Resistance

    Not yet reported Wanpen Vongpatanasin Est. completion 2025-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02176096

    Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial

    Not yet reported University of Manitoba 4 participants Est. completion 2017-08-02 1 site
    Obstructive sleep apnea Other conditions: Glycogen Storage Disorder Type 1, Hypoglycemia, Cornstarch
    View official trial listing →
  • Status unknown NCT NCT02255006

    Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury

    Not yet reported Kyunghee University Medical Center 36 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02269735

    A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

    Not yet reported Merck Sharp & Dohme LLC 74 participants Est. completion 2016-07-29 Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02746432

    Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial

    Not yet reported King Saud University 144 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT02827526

    Methadone and Ketamine for Spinal Surgery

    Not yet reported Endeavor Health 130 participants Est. completion 2021-02 1 site
    Other conditions: Pain
    View official trial listing →
  • Withdrawn NCT NCT02982551

    Insulin Modulation of fMRI Connectivity in Healthy Adults

    Not yet reported University of Pittsburgh Est. completion 2017-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03454087

    Study of Early Enteral Dextrose in Sepsis

    Not yet reported University of Pittsburgh 58 participants Est. completion 2020-04-01 1 site Stand-alone
    Other conditions: Sepsis
    View official trial listing →
  • Completed NCT NCT03461510

    Type 2 Diabetes and the Brain in Adolescents

    Not yet reported Nemours Children's Clinic 18 participants Est. completion 2019-01-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Obesity, Pediatric Obesity, Insulin Resistance, Dysglycemia, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT03834493

    Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

    Not yet reported Merck Sharp & Dohme LLC 1244 participants Est. completion 2026-06-08 259 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT03834506

    Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

    Not yet reported Merck Sharp & Dohme LLC 1030 participants Est. completion 2023-07-18 215 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT03955237

    Perioperative Fluid Management According to the Preoperative and Perioperative Glucose Level

    Not yet reported Istanbul University 250 participants Est. completion 2016-07
    Other conditions: Perioperative Complication
    View official trial listing →
  • Completed NCT NCT04012138

    Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

    Not yet reported Nantes University Hospital 419 participants Est. completion 2025-12-20 16 sites
    Other conditions: Hyperkalemia
    View official trial listing →
  • Terminated NCT NCT04907227

    Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension

    Not yet reported Merck Sharp & Dohme LLC 81 participants Est. completion 2023-07-18 20 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT05947981

    Pre-operative 5% Dextrose Infusion & PONV

    Not yet reported Cairo University 105 participants Est. completion 2024-01-31 1 site
    Other conditions: Nausea, Postoperative
    View official trial listing →
  • Completed NCT NCT05961722

    Preoperative Intravenous Fluid Type and Postoperative Nausea

    Ankara Etlik City Hospital 90 participants Est. completion 2024-08-05 1 site
    Other conditions: Post Operative Pain, Nausea and Vomiting, Postoperative, Anxiety
    View official trial listing →
  • Withdrawn NCT NCT05985135

    Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

    Not yet reported Mayo Clinic Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT06288542

    Preoperative Dextrose Infusion and Postoperative Nausea and Vomiting

    Not yet reported Cairo University 111 participants Est. completion 2024-05-01 Stand-alone
    Other conditions: Effect of Dextrose on Postoperative Nausea and Vomiting
    View official trial listing →
  • Completed NCT NCT06319144

    Effect of Intravenous 5% Dextrose Infusion During Recovery from Anesthesia on the Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy

    Not yet reported Weifang Medical University 102 participants Est. completion 2024-06-22 1 site
    Other conditions: Insulin Resistance, Postoperative Nausea and Vomiting, Quality of Recovery, Dizzyness
    View official trial listing →
  • Completed NCT NCT06472258

    Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative Study

    Not yet reported RESnTEC, Institute of Research 104 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Malaria
    View official trial listing →
  • Not yet recruiting NCT NCT06726980

    Effects of Dextrose Versus Saline Infusion on Intrathecal Morphine-Induced Postoperative Nausea and Vomiting During Gynecological Abdominal Surgeries: Randomized Controlled Double-blind Study

    Not yet reported Assiut University 63 participants Est. completion 2026-02-01 Stand-alone
    Other conditions: Gynecological Abdominal Surgeries
    View official trial listing →
  • Not yet recruiting NCT NCT07451561

    Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.

    Not yet reported Sohag University 74 participants Est. completion 2027-03 1 site
    Other conditions: Acute Aluminum Phosphide Poisoned Cases
    View official trial listing →
  • Not yet recruiting NCT NCT07564063

    Enhanced Recovery After Surgery in Hysterectomy Patients

    Not yet reported Cairo University 78 participants Est. completion 2027-01-01 1 site
    Other conditions: Enhanced Recovery After Surgery (ERAS) Protocol
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.